Medical Marijuana ProCon.org HOME | CLOSE

1. Name: David J. Rog
2. Title: Walton Centre for Neurology and Neurosurgery, University of Liverpool, UK
3. Medical Marijuana
Position:
No position found to the question "Should marijuana be a medical option?"
4. Reasoning:

"BACKGROUND: Central pain in multiple sclerosis (MS) is common and often refractory to treatment...

CONCLUSIONS: Cannabis-based medicine [Sativex] is effective in reducing pain and sleep disturbance in patients with multiple sclerosis related central neuropathic pain and is mostly well tolerated." ("Randomized, Controlled Trial of Cannabis-Based Medicine in Central Pain in Multiple Sclerosis." Neurology 9/05)
5. Credibility
Ranking:

Organization/VIP/Other
Those individuals and organizations that do not fit into the other star categories

6. Involvement:
  • Walton Centre for Neurology and Neurosurgery, University of Liverpool, UK
7. Education:
  • Bachelor of Medicine and Bachelor of Surgery (BMBS), school unknown
8. Relevant Affiliations/Honors:
  • The 2006 Whitaker Prize for MS Research for "An RCT with Open-label Extension of Sativex, a Cannabis-Based Medicine (CBM), in MS-related Central Pain"
9. Contact Info:
Phone: +44 151 525 3611, Main office at University of Liverpool Fax: None listed
E-Mail:   djrdjr@doctors.org.uk
Web Sitewww.thewaltoncentre.nhs.uk
10. Other: Select Publications:
  • Co-author, "Double Blind, Randomised Placebo Controlled, Crossover Trial of Topiramate in Central Neuropathic Paind Due to Multiple Sclerosis," Journal of Neurology, Neurosurgery and Psychiatry 2003, 74: 1448-1460
  • Presenter of "Double Blind, Randomised, Parallel Group Placebo Controlled Study of Sativex in Central Neuropathic Pain in MS" to the American Pain Society on March-April 2005 in Boston, and to the 19th Congress of the European Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS) on Sept. 2003 in Milan
  • Co-presenter of "Variability in the Qualities of Chronic Neuropathic Pain in Multiple Sclerosis Assessed by the Neuropathic Pain Scale (NPS)" and "Burden of Neuropathic Pain in MS" to the American and European Committees for Treatment and Research in Multiple Sclerosis (ACTIMS-ECTRIMS) on Sept. 2002 in Maryland
HOME | CLOSE